\
&
Contact us
Published on | 1 year ago
Programmes ERC ERCThis week the European Research Council (ERC) 2025 work programme has been published, including the provisional call calendar, after it was adopted by the European Commission. The work programme includes a call for each main frontier research grant, i.e. Starting, Consolidator, Advanced and Synergy Grant, plus a call for complementary funding for ERC Principal Investigators, i.e. the Proof of Concept Grant with two submission deadlines. The work programme contains also several other actions including public procurement, e.g. support to programme monitoring and evaluation, support to the Europe PMC initiative and assessment of the scientific impact of ERC-funded research. The main novelties compared to the previous (2024) work programme are:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.